Sjögren’s syndrome has no known cure, and anyone claiming to have fully eliminated the disease is likely describing something different: a significant reduction in symptoms that makes daily life feel normal again. That distinction matters, because while the underlying autoimmune process doesn’t switch off, many people do reach a state of low disease activity where dryness, pain, and fatigue become manageable or even minimal. The stories you’ll find online about “curing” Sjögren’s are really stories about finding the right combination of treatments, lifestyle changes, and symptom management. Here’s what actually works and what the evidence supports.
Why “Cure” Stories Are Really Remission Stories
Sjögren’s is a chronic autoimmune disease that can damage moisture-producing glands over time. It predominantly affects women, with female patients outnumbering males by roughly 14 to 1. The disease can remain stable, worsen, or go into periods of remission, but once gland damage occurs, normal function rarely returns. Treatment focuses on managing symptoms rather than eliminating the disease itself.
That said, disease activity is measured on a clinical scale, and getting below a score of 5 out of a possible high score qualifies as low disease activity. Some people get there and stay there for years. Features that remain stable for at least 12 months are even scored as essentially resolved. So while the immune system dysfunction persists, the practical experience of the disease can change dramatically.
Medications That Reduce Symptoms
The most direct relief for dry mouth and dry eyes comes from medications that stimulate whatever gland function you still have. Pilocarpine, a plant-derived compound that activates the receptors on moisture-producing glands, improved both oral and eye dryness in more than 85% of patients in clinical studies. A single 5 mg dose produced measurable increases in tear volume within 15 to 30 minutes and significant improvement in eye surface health within an hour. Side effects at that dose were mild: sweating in about 7% of cases and mild nausea in 4%. Doctors typically start with a low dose and increase gradually. A similar medication, cevimeline, has shown improvements in tear production and eye surface damage within one month of use.
For joint pain, fatigue, and other symptoms beyond dryness, hydroxychloroquine is the most commonly prescribed option. However, the evidence for it is surprisingly weak. A major randomized trial found that hydroxychloroquine performed no better than a placebo for dryness, pain, or fatigue over 24 weeks. Only about 18% of patients in both groups saw meaningful improvement, suggesting the benefit many patients report may be a placebo effect. Despite this, some rheumatologists still prescribe it for 6 to 12 months as a trial, particularly when systemic symptoms are prominent.
For people with severe disease that doesn’t respond to standard treatments, newer biologic therapies targeting immune cells show more promise. A combination approach using two drugs that deplete overactive immune cells reduced disease activity scores from 11 to 5 over about 16 months in a clinical trial, essentially moving patients from moderate-high disease activity into the low-activity range. This approach also improved saliva production and achieved near-complete clearance of the problematic immune cells from salivary gland tissue.
Dietary Changes That Show Real Effects
Diet is where many “I cured my Sjögren’s” stories begin, and there is legitimate science behind some of these claims. A systematic review of nutritional interventions found several dietary patterns associated with measurable improvements.
Diets high in saturated fats were linked to reduced saliva flow and increased immune cell infiltration in salivary glands. Cutting back on these fats and shifting toward a whole-food, plant-based diet improved both dry mouth and dry eyes in a small human study over just four weeks. Higher adherence to a Mediterranean-style diet (rich in vegetables, olive oil, fish, and whole grains) was associated with reduced eye dryness in patients with Sjögren’s.
Calorie restriction strategies also showed consistent benefits in animal studies, with a 40% calorie reduction improving saliva production and reducing gland inflammation significantly. Animals allowed to eat freely had gland inflammation scores roughly three times higher than those on restricted diets. Gluten-free diets reduced certain inflammatory immune cells in salivary glands by nearly 50% in animal models, and showed some improvement in tear production in humans, though dry mouth didn’t change as clearly.
None of these dietary approaches cured the disease. But reducing inflammatory foods and emphasizing plant-rich, whole-food eating patterns appears to lower the overall inflammatory burden, which can translate to fewer and milder symptoms.
Low-Dose Naltrexone: A Growing Interest
One treatment that frequently appears in patient forums is low-dose naltrexone (LDN), a repurposed medication with anti-inflammatory and pain-relieving properties used at doses far below its original purpose. The peer-reviewed evidence is still limited to case reports rather than large trials, but the results are encouraging for joint pain specifically.
In published cases, patients started at 0.5 to 1 mg daily and gradually increased to a target of 4.5 mg. One 24-year-old woman became completely free of joint pain at 2 mg daily, with her inflammatory blood markers normalizing. A 66-year-old patient saw significant improvement in joint pain and headaches, with inflammatory markers dropping to normal for the first time. These are individual stories, not proof of broad effectiveness, but they reflect the kind of experience that drives “I cured my Sjögren’s” searches. LDN appeared most helpful for musculoskeletal symptoms rather than dryness.
Protecting Your Teeth and Eyes Long-Term
Chronic dry mouth creates an environment where dental decay accelerates rapidly, and tooth loss is one of the most common long-term consequences of Sjögren’s. Clinical guidelines strongly recommend topical fluoride for all patients with Sjögren’s-related dry mouth. This isn’t optional or nice-to-have: it’s considered the single strongest recommendation in oral care guidelines for this disease. Prescription-strength fluoride toothpaste or custom fluoride trays, combined with more frequent dental visits, can prevent the rampant cavities that otherwise develop.
For severe dry eyes that don’t respond to standard lubricating drops, autologous serum eye drops offer another level of treatment. These are made from your own blood and contain growth factors, vitamin A, and hyaluronic acid that closely mimic natural tears. They promote healing of the eye surface, regenerate protective cells, and lack the preservatives in commercial drops that can cause additional irritation. Patients with severe dryness who hadn’t improved with regular lubricants used 20% serum drops every two hours during waking hours for at least six months. The treatment was equally effective whether the disease was in an active flare or a quieter phase.
What “Feeling Cured” Actually Looks Like
People who describe themselves as having beaten Sjögren’s have typically done several things at once. They found the right medication to address their most disruptive symptoms, whether that’s a gland-stimulating drug for dryness, a biologic for systemic inflammation, or LDN for joint pain. They changed their diet in ways that reduced their overall inflammatory load. They stayed aggressive about dental and eye care to prevent irreversible damage. And they adjusted their expectations, recognizing that a day with minimal symptoms is a realistic and meaningful goal.
The disease activity scores used in clinical research confirm that this is achievable. Moving from a score of 11 to 5 doesn’t sound dramatic on paper, but it represents the difference between a disease that dominates your daily life and one that sits quietly in the background. That shift is what most people mean when they say they cured their Sjögren’s, and for many patients, it’s within reach.